Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. completed
Appointed director
Cosmos Health Inc. (COSM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
10/03/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
08/15/2023 8-K Quarterly results
Docs: "Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $ Million H1 2022; Book Value per Share Exceeds $4.04 CHICAGO, IL / August 15, 2023 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported its financial results for the second quarter of 2023. Q2 and H1 2023 Financial Highlights"
08/07/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from Armanino LLP regarding change in independent registered public accounting firm"
07/25/2023 8-K Quarterly results
07/06/2023 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "SOURCE:"
05/31/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Binding Letter of Intent by and among Cosmos Health Inc. and Docpharm GmbH and Dr. Mathias Krebs"
05/11/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Stock Purchase Agreement by and among Cosmos Health Inc. and Konstantinos-Gaston Kanaroglou and Konstantina-Mathilde Kanaroglou regarding Cana Laboratories Holding (Cyprus) Limited"
04/18/2023 8-K Quarterly results
03/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Secured Promissory Note issued by Cana Laboratories Holdings (Cyprus) Limited",
"Cana Holdings Share Pledge Agreement",
"Cana Pharmaceutical Share Pledge Agreement"
02/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Press Release titled “Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer”"
01/17/2023 8-K Quarterly results
01/12/2023 8-K Quarterly results
12/20/2022 8-K Quarterly results
12/16/2022 8-K Quarterly results
12/05/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
11/16/2022 8-K Quarterly results
Docs: "Cosmos Health Reports Third Quarter 2022 Financial Results"
10/18/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
09/27/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Company Presentation dated September 2022"
08/23/2022 8-K Quarterly results
07/29/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles o...
Docs: "Amendment to the Certificate of Designations of Rights and Preferences of Series A Convertible Preferred Stock",
"Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company’s Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People’s Lives"
07/25/2022 8-K Quarterly results
05/18/2022 8-K Quarterly results
04/28/2022 8-K Resignation/termination of a director, Appointed a new director
04/19/2022 8-K Financial Statements and Exhibits  Interactive Data
Docs: "Cosmos Holdings Inc. Press Release titled Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021"
03/01/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
12/20/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Cosmos Holdings Announces Shareholder Approval of Private Offering Cosmos Holdings December 20, 2021 CHICAGO, December 20, 2021 -- Cosmos Holdings, Inc. , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today provided a business update with respect to its progress towards its direct listing efforts on the Nasdaq Capital Markets. On September 15, 2021 the Company’s Board of Directors approved a private offering whereby it would sell 5,000,000 shares of a newly created class of Series A Preferred Stock and warrants to a private investor in exchange for $5,000,000. As a condition to closing of the sale, the Company’s Common Stock must be approved for l..."
12/09/2021 8-K/A Quarterly results
12/08/2021 8-K Quarterly results
11/17/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
09/20/2021 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Form of Securities Purchase Agreement",
"Form of Registration Rights Agreement",
"Form of Note",
"Pro Forma Balance Sheet",
"Pro Forma Stockholders’ Equity",
"Press Release"
08/27/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy